Skip to main content

Advertisement

SpringerLink
Log in

Expression and anatomical distribution of TIM-containing molecules in Langerhans cell sarcoma

  • Original paper
  • Published:
Journal of Molecular Histology Aims and scope Submit manuscript

Abstract

Signals from the T cell immunoglobulin and mucin-domain (TIM)-containing molecules have been demonstrated to be involved in regulating the progress of carcinoma. However, the expression and anatomical distribution of TIMs in Langerhans cell sarcoma (LCS), which is a rare malignancy derived from dendritic cells of the epidermis, has yet to be determined. In this study, the expression of TIM-1, TIM-3 and TIM-4 in LCS samples were detected by immunohistochemistry. Our results showed that these three molecules were found in LCS sections. At the cellular level, these molecules were found on the cell membrane and in the cytoplasm. Immunofluorescence double-staining demonstrated that these TIMs were co-expressed with Langerin, a potential biomarker for detecting LCS. In addition, TIM-1 was also expressed on CD68+ macrophages and CK-18+ epithelial cells, while TIM-3 and TIM-4 were expressed on all cell types investigated, including CD3+T cells, CD68+ macrophages, CD11c+ dendritic cells, CD16+ NK Cells, CD31+ endothelial cells and CK-18+ epithelial cells. Interestingly, TIMs were also co-expressed with some members of the B7 superfamily, including B7-H1, B7-H3 and B7-H4 on sarcoma cells. Our results clearly showed the characteristic expression and anatomical distribution of TIMs in LCS, and a clear understanding of their functional roles may further elucidate the pathogenesis of this carcinoma and potentially contribute to the development of novel immunotherapeutic strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Anderson AC (2012) Tim-3, a negative regulator of anti-tumor immunity. Curr Opin Immunol 24(2):213–216

    Article  PubMed  CAS  Google Scholar 

  • Chiba S, Baghdadi M, Akiba H et al (2012) Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1. Nat Immunol 13(9):832–842

    Article  PubMed  CAS  Google Scholar 

  • Freeman GJ, Casasnovas JM, Umetsu DT et al (2010) TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity. Immunol Rev 235(1):172–189

    PubMed  CAS  Google Scholar 

  • Hashiguchi M, Kobori H, Ritprajak P et al (2008) Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7–H3 and enhances T cell responses. Proc Natl Acad Sci USA 105(2008):10495–10500

    Article  PubMed  CAS  Google Scholar 

  • He W, Fang Z, Wang F et al (2010) Galectin-9 significantly prolongs the survival of fully mismatched cardiac allografts in mice. Transplantation 88(6):782–790

    Article  Google Scholar 

  • Huang X, Bai X, Cao Y et al (2010) Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion. J Exp Med 207(3):505–520

    Article  PubMed  CAS  Google Scholar 

  • Lau SK, Chu PG, Weiss LM (2008) Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders. Am J Surg Pathol 32(4):615–619

    Article  PubMed  Google Scholar 

  • Li H, Wang C, Guo G et al (2012a) The characteristic expression of B7-associated proteins in Langerhans cell sarcoma. Acta Histochem 114(7):733–743

    Article  PubMed  CAS  Google Scholar 

  • Li H, Wu K, Tao K et al (2012b) Tim-3/galectin-9 signaling pathway mediates T cell dysfunction and predicts poor prognosis in patients with HBV-associated hepatocellular carcinoma. Hepatology

  • Miyanishi M, Tada K, Koike M et al (2007) Identification of Tim4 as a phosphatidylserine receptor. Nature 450(7168):435–439

    Article  PubMed  CAS  Google Scholar 

  • Monney L, Sabatos CA, Gaglia JL et al (2002) Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415(6871):536–541

    Article  PubMed  CAS  Google Scholar 

  • Nakayama M, Akiba H, Takeda K et al (2009) Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation. Blood 113(16):3821–3830

    Article  PubMed  CAS  Google Scholar 

  • Nakayama M, Takahashi K, Hori M et al (2010) Langerhans cell sarcoma of the cervical lymph node: a case report and literature review. Auris Nasus Larynx 37(6):750–753

    Article  PubMed  Google Scholar 

  • Nozaki Y, Nikolic-Paterson DJ, Snelgrove SL et al (2012) Endogenous Tim-1 (Kim-1) promotes T-cell responses and cell-mediated injury in experimental crescentic glomerulonephritis. Kidney Int 81(9):844–855

    Article  PubMed  CAS  Google Scholar 

  • Rennert PD (2011) Novel roles for TIM-1 in immunity and infection. Immunol Lett 141(1):28–35

    Article  PubMed  CAS  Google Scholar 

  • Rodriguez-Manzanet R, DeKruyff R, Kuchroo VK et al (2009) The costimulatory role of TIM molecules. Immunol Rev 229(1):259–270

    Article  PubMed  CAS  Google Scholar 

  • Rodriguez-Manzanet R, Sanjuan MA, Wu HY et al (2010) T and B cell hyperactivity and autoimmunity associated with niche-specific defects in apoptotic body clearance in TIM-4-deficient mice. Proc Natl Acad Sci USA 107(19):8706–8711

    Article  PubMed  CAS  Google Scholar 

  • Sánchez-Fueyo A, Tian J, Picarella D et al (2003) Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol 4(11):1093–1101

    Article  PubMed  Google Scholar 

  • Saresella M, Rainone V, Al-Daghri NM et al (2012) The PD-1/PD-L1 pathway in human pathology. Curr Mol Med 12(3):259–267

    Article  PubMed  CAS  Google Scholar 

  • Seki M, Oomizu S, Sakata KM et al (2008) Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol 127(1):78–88

    Article  PubMed  CAS  Google Scholar 

  • Sica GL, Choi IH, Zhu G et al (2003) B7–H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 18(6):849–861

    Article  PubMed  CAS  Google Scholar 

  • Sonar SS, Hsu YM, Conrad ML et al (2010) Antagonism of TIM-1 blocks the development of disease in a humanized mouse model of allergic asthma. J Clin Invest 120(8):2767–2781

    Article  PubMed  CAS  Google Scholar 

  • Uchida K, Kobayashi S, Inukai T et al (2008) Langerhans cell sarcoma emanating from the upper arm skin: successful treatment by MAID regimen. J Orthop Sci 13:89–93

    Article  PubMed  Google Scholar 

  • Wong K, Valdez PA, Tan C et al (2010) Phosphatidylserine receptor Tim-4 is essential for the maintenance of the homeostatic state of resident peritoneal macrophages. Proc Natl Acad Sci USA 107(19):8712–8717

    Article  PubMed  CAS  Google Scholar 

  • Yang PC, Xing Z, Berin CM et al (2007) TIM-4 expressed by mucosal dendritic cells plays a critical role in food antigen-specific Th2 differentiation and intestinal allergy. Gastroenterology 133(5):1522–1533

    Article  PubMed  CAS  Google Scholar 

  • Zhuang X, Zhang X, Xia X et al (2012) Ectopic expression of TIM-3 in lung cancers: a potential independent prognostic factor for patients with NSCLC. Am J Clin Pathol 137(6):978–985

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by grants from the National Natural Science Foundation of China (NSFC No. 81171585, 30971099 and 61141012) and Natural Science Foundation of Chongqing (No CSTC2011BB5037).

Conflicts of interest

None of the authors have any conflicts of interest related to this manuscript.

Author information

Authors and Affiliations

  1. Institute of Immunology, PLA, Third Military Medical University, Chongqing, 400038, People’s Republic of China

    Jingwei Li, Dayan Cao, Yuzhang Wu & Yongwen Chen

  2. Undergraduate Administration Office, Third Military Medical University, Chongqing, 400037, People’s Republic of China

    Jingwei Li & Dayan Cao

  3. Department of Emergency, South-West Hospital, PLA, Third Military Medical University, Chongqing, 400037, People’s Republic of China

    Guoning Guo

Authors
  1. Jingwei Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dayan Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Guoning Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yuzhang Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yongwen Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yongwen Chen.

Additional information

Jingwei Li and Dayan Cao equally contributed to this work.

Electronic supplementary material

Below is the link to the electronic supplementary material.

10735_2012_9475_MOESM1_ESM.tif

Supplmental Figure 1 The morphology of TIM-1 positive cells in LCS sample sections detected by immunofluorescence double-staining. Immunofluorescence double-staining showed that TIM-1 was expressed on CD68+ macrophages and CK-18+ epithelial cells, while it was absent on CD3+ T cells, CD11c+DCs, CD16+ monocytes, and CD31+ endothelial cells. Arrow indicates positive cells. Nuclei were stained with DAPI. Scale bar = 20 μm. (TIFF 6903 kb)

10735_2012_9475_MOESM2_ESM.tif

Supplmental Figure 2 The morphology of TIM-3positive cells in LCS sample sections detected by immunofluorescence double-staining. Immunofluorescence double-staining showed that TIM-3 was expressed on CD3+ T cells, CD68+ macrophages, CD11c+ dendritic cells, CD16+ monocytes, CD31+ endothelial cells and CK-18+ epithelial cells. Arrow indicates positive cells. Nuclei were stained with DAPI. Scale bar = 20 μm. (TIFF 7448 kb)

10735_2012_9475_MOESM3_ESM.tif

Supplmental Figure 3 The morphology of TIM-4positive cells in LCS sample sections was detected by immunofluorescence double-staining. Immunofluorescence double-staining showed that TIM-4 was expressed on CD3+ T cells, CD68+ macrophages, CD11c+ dendritic cells, CD16+ monocytes, CD31+ endothelial cells and CK-18+ epithelial cells. Arrow indicates positive cells. Nuclei were stained with DAPI. Scale bar = 20 μm. (TIFF 5579 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, J., Cao, D., Guo, G. et al. Expression and anatomical distribution of TIM-containing molecules in Langerhans cell sarcoma. J Mol Hist 44, 213–220 (2013). https://doi.org/10.1007/s10735-012-9475-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10735-012-9475-2

Keywords

Search

Navigation